english.prescrire.org > Topics > Advancing healthcare policy > Advancing healthcare policy in Europe: a chronological recap of actions > 2016 Recap > Why You Should Be Concerned About TTIP and Access to Medicines (2/2016)

Advancing healthcare policy

Advancing healthcare policy in Europe: a chronological recap of actions

A recap of actions in 2016
Why You Should Be Concerned About TTIP and Access to Medicines (February 2016)


18 February 2016

Joint Position Statement by HAI, The Commons Network and Public Citizen.

Summary

Both the European Union (EU) and the United States (US) are confronted with increasingly high medicine prices. European Member States are facing a looming access to medicines crisis as they struggle to afford new, patented, high-priced medicines. The Transatlantic Trade and Investment Partnership Agreement (TTIP), now under negotiation, could hamper needed changes towards affordability, needs-driven innovation and alternative incentive structures.

©HAI, The Commons Network, Public Citizen 2016

> Click here to download the Position Statement (pdf, 59 Ko)